Cancers have complex etiology and pose a significant impact from the health care
perspective apart from the socio-economic implications. The enormity of challenge posed by …

Introduction Multiple new drugs have been approved over the past 5 years for the treatment
of relapsed/refractory multiple myeloma (RRMM), and these are being increasingly widely …

The main goal of the present study was to examine if the RNA-sequencing (RNAseq)-based
ERBB2/HER2 expression level in malignant plasma cells from multiple myeloma (MM) …

Multiple myeloma is the second most frequent hematologic malignancy worldwide with high
morbidity and mortality. Although it is considered an incurable disease, the enhanced …

Multiple myeloma (MM), marked by abnormal proliferation of plasma cells and production of
monoclonal immunoglobulin heavy or light chains in the majority of patients, has traditionally …

The review examines multiple myeloma, including pathophysiology, conventional
treatments, current management strategies, treatment challenges, and emerging therapies …

Multiple Myeloma (MM), a prevalent hematological cancer, remains a challenge due to its
intricate nature and variable outcomes. Cytogenetics, the study of chromosome structure …

Objectives The goal of the research was to assess the quantitative relationship between
median progression-free survival (PFS) and median overall survival (OS) specifically among …